Provident Co of the Employees of the Hebrew University LTD
Net buyer this quarter
$131M
19
+$46.4M
60.1%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 SMH | $29.1M | 22.23% | Not reported | +331.1% | Q1 2024 |
 INTC | $11.2M | 8.57% | 0.00% | New | Q2 2026 |
 TSM | $7.39M | 5.65% | 0.00% | New | Q2 2026 |
 AMZN | $7.04M | 5.38% | 0.00% | +27.2% | Q1 2024 |
 PANW | $5.33M | 4.08% | 0.00% | New | Q2 2026 |
 EMXC | $4.6M | 3.52% | Not reported | Not reported | Q1 2024 |
 GS | $3.99M | 3.05% | 0.00% | +184.8% | Q1 2026 |
 SEDG | $3.72M | 2.84% | 0.10% | Not reported | Q1 2026 |
 DK | $3.69M | 2.82% | 0.12% | Not reported | Q1 2026 |
 V | $2.6M | 1.99% | 0.00% | Not reported | Q1 2024 |
 QTUM | $2.36M | 1.80% | Not reported | New | Q2 2026 |
 PLTR | $2.19M | 1.67% | 0.00% | New | Q2 2026 |
 LLY | $1.95M | 1.49% | 0.00% | New | Q2 2026 |
 BWXT | $1.91M | 1.46% | 0.01% | Not reported | Q1 2026 |
 MSFT | $1.59M | 1.21% | 0.00% | New | Q2 2026 |
 CBRS | $1.45M | 1.11% | Not reported | New | Q2 2026 |
 META | $1.36M | 1.04% | Not reported | -50.0% | Q4 2025 |
 MA | $369K | 0.28% | 0.00% | -15.0% | Q1 2024 |
 SPY | $355K | 0.27% | Not reported | Not reported | Q4 2025 |
| Q1 2026 | |||||
| AMZN | $4.83M | 7.62% | 0.00% | -1.1% | Q1 2024 |
| SMH | $3.94M | 6.22% | Not reported | Not reported | Q1 2024 |
| EMXC | $3.54M | 5.58% | Not reported | -4.1% | Q1 2024 |
| DK | $3.28M | 5.17% | 0.12% | New | Q1 2026 |
| SEDG | $3.25M | 5.12% | 0.10% | New | Q1 2026 |
 ICL | $2.91M | 4.58% | 0.04% | -1.1% | Q1 2024 |
| META | $2.76M | 4.35% | Not reported | Not reported | Q4 2025 |
| V | $2.29M | 3.61% | 0.00% | Not reported | Q1 2024 |
 FLEX | $2.1M | 3.32% | 0.01% | -47.6% | Q1 2025 |
| BWXT | $2.01M | 3.17% | 0.01% | New | Q1 2026 |
 NKE | $1.79M | 2.82% | 0.00% | Not reported | Q2 2024 |
 UBER | $1.31M | 2.06% | 0.00% | Not reported | Q1 2025 |
| GS | $1.17M | 1.85% | 0.00% | New | Q1 2026 |
 TATT | $809K | 1.28% | 0.15% | Not reported | Q2 2025 |
| MA | $422K | 0.67% | 0.00% | -79.1% | Q1 2024 |
| SPY | $309K | 0.49% | Not reported | Not reported | Q4 2025 |
 ABNB | $302K | 0.48% | Not reported | -77.6% | Q1 2025 |
| Q4 2025 | |||||
| AMZN | $5.42M | 5.62% | 0.00% | Not reported | Q1 2024 |
| FLEX | $3.71M | 3.85% | 0.02% | Not reported | Q1 2025 |
| EMXC | $3.41M | 3.54% | Not reported | Not reported | Q1 2024 |
| ICL | $3.3M | 3.42% | 0.04% | +11.9% | Q1 2024 |
| META | $3.18M | 3.30% | Not reported | New | Q4 2025 |
| V | $2.66M | 2.76% | 0.00% | Not reported | Q1 2024 |
| MA | $2.31M | 2.40% | 0.00% | Not reported | Q1 2024 |
 BIIB | $2.2M | 2.29% | 0.01% | Not reported | Q1 2024 |
| NKE | $2.15M | 2.23% | 0.00% | Not reported | Q2 2024 |
 MELI | $1.94M | 2.01% | 0.00% | Not reported | Q1 2025 |
 BRK.B | $1.87M | 1.94% | Not reported | Not reported | Q3 2024 |
 COST | $1.77M | 1.83% | 0.00% | +41.5% | Q2 2025 |
 APO | $1.66M | 1.73% | 0.00% | New | Q4 2025 |
 PLD | $1.65M | 1.71% | 0.00% | Not reported | Q1 2024 |
| UBER | $1.49M | 1.54% | 0.00% | Not reported | Q1 2025 |
| ABNB | $1.45M | 1.50% | Not reported | Not reported | Q1 2025 |
| TATT | $889K | 0.92% | 0.15% | -20.4% | Q2 2025 |
 MRNA | $485K | 0.50% | 0.00% | Not reported | Q1 2024 |
| SPY | $324K | 0.34% | Not reported | New | Q4 2025 |
| Q3 2025 | |||||
 NVDA | $5.97M | 5.97% | 0.00% | -11.2% | Q1 2024 |
| AMZN | $5.14M | 5.14% | 0.00% | +4.1% | Q1 2024 |
| FLEX | $3.55M | 3.54% | 0.02% | Not reported | Q1 2025 |
| ICL | $3.2M | 3.20% | 0.04% | +0.2% | Q1 2024 |
| EMXC | $3.16M | 3.16% | Not reported | Not reported | Q1 2024 |
| V | $2.58M | 2.58% | 0.00% | Not reported | Q1 2024 |
| NKE | $2.35M | 2.35% | 0.00% | Not reported | Q2 2024 |
| MA | $2.29M | 2.29% | 0.00% | Not reported | Q1 2024 |
 ORCL | $2.27M | 2.26% | 0.00% | -23.8% | Q1 2025 |
| MELI | $2.24M | 2.24% | 0.00% | +156.8% | Q1 2025 |
| BRK.B | $1.87M | 1.86% | Not reported | Not reported | Q3 2024 |
| UBER | $1.78M | 1.78% | 0.00% | Not reported | Q1 2025 |
| BIIB | $1.75M | 1.75% | 0.01% | Not reported | Q1 2024 |
| PLD | $1.47M | 1.47% | 0.00% | Not reported | Q1 2024 |
| COST | $1.34M | 1.34% | 0.00% | Not reported | Q2 2025 |
| ABNB | $1.29M | 1.29% | Not reported | Not reported | Q1 2025 |
| TATT | $1.1M | 1.10% | 0.19% | Not reported | Q2 2025 |
| MRNA | $424K | 0.42% | 0.00% | Not reported | Q1 2024 |